Prevalence of Amyloidosis in Trauma Patients

NCT ID: NCT06527521

Last Updated: 2025-12-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

246 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-11-13

Study Completion Date

2026-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to determine the frequency of amyloidosis among patients undergoing trauma surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Amyloidosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Traumatologic surgery

Patients undergoing trauma surgery

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men and women included in the waiting list for scheduled trauma surgery with at least one of the following criteria defined as red flags: Over 65 years old; Possible family history of amyloidosis, Cardiac pathology: aortic stenosis, presence of left ventricular hypertrophy defined as interventricular septal thickness \> 12mm measured by echocardiography, history of previous brady- or tachyarrhythmias including cardiac conduction blocks, history of syncope or presyncope, pro BNP \> 300 in previous blood tests; History of sensory peripheral neuropathy; History of nephropathy without etiological diagnosis; History of liver disease without a clear cause.
* Ability to cooperate in the necessary evaluations.
* Signed informed consent for inclusion in the study, either by the participant or their legal representative.

Exclusion Criteria

\- Participants previously diagnosed with amyloidosis cannot be included in the study.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Consorci Sanitari de l'Alt Penedès i Garraf

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lidia Tikhomirova, MD

Role: PRINCIPAL_INVESTIGATOR

CSAPG

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Consorci Sanitari Alt Penedes i Garraf-Hospital Sant Camil

Sant Pere de Ribes, Barcelona, Spain

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Lidia Tikhomirova, MD

Role: CONTACT

+34 938960025

Noemí Casaponsa

Role: CONTACT

+34 938960025 ext. 43197

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Lidia Tikhomirova

Role: primary

+34 938960025

Noemí Casaponsa

Role: backup

+34 938960025 ext. 43197

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CSAPG-61

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.